Trials / Not Yet Recruiting
Not Yet RecruitingNCT07482384
Supporting Health Including Endocrine Treatment for Long Duration
Supporting Health Including Endocrine Treatment for Long Duration: A Pilot Intervention
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- Female
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
This research is being done to pilot an intervention which aims to test a new web- and mobile application ("app")-based supportive care tool (SHIELD portal) and to assess the feasibility of enrolling female breast cancer patients with hormone receptor-positive disease long-term endocrine treatment.
Detailed description
This research study is a single-arm intervention pilot study to assess the feasibility of enrolling female breast cancer patients with hormone receptor-positive disease prescribed long-term endocrine treatment. The SHIELD portal is designed to help monitor the frequency and variation in cancer and treatment-related issues and to share self-management information and resources to those interested in particular issues or who indicate a specific concern, symptom or side effect on measures designed to assess and track salient symptoms. Research study procedures include screening for eligibility, in-clinic and virtual approaches for recruitment, gaining access and using the SHIELD web- and mobile app-based supportive care portal, and completing of survey assessments on the SHIELD portal. Participation in this research study is expected to last 3 months. It is expected that 30 people will take part in this research study.
Conditions
- Breast Cancer
- Breast Cancer - Female
- Breast Carcinoma
- ER Positive Breast Cancer
- PR-Positive Breast Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | SHIELD portal | All participants will receive access to the SHIELD portal. The portal includes educational modules, symptom and side effect tracking, tailored informational resources, and health behavior tools. Participants can access the portal via smartphone, tablet, or computer. The portal is HIPAA compliant and HITRUST certified. |
Timeline
- Start date
- 2026-05-01
- Primary completion
- 2027-01-01
- Completion
- 2027-05-01
- First posted
- 2026-03-19
- Last updated
- 2026-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07482384. Inclusion in this directory is not an endorsement.